<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302659/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302659</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Intestinal LKB1 loss drives a pre-malignant program along the serrated cancer pathway [bulkRNA-seq]</name><description>Background &amp; Aims Heterozygous inactivating mutations of Serine Threonine Kinase 11 (STK11)/Liver Kinase B1 (LKB1) are causative to the Peutz-Jeghers syndrome (PJS), a hereditary disease characterized by gastrointestinal hamartomatous polyposis and increased cancer susceptibility. While LKB1 loss-induced polyp formation has been ascribed to non-epithelial tissues, how LKB1 deficiency increases cancer risk of patients by altering the phenotypical landscape and hierarchical organization of epithelial tissues remains poorly understood. Methods Using CRISPR/Cas9, we generated heterozygous and homozygous Lkb1-deficient mouse small intestinal and human colon organoids. These organoids were characterized by an integrated approach that combines imaging, bulk and single-cell RNA sequencing and growth factor dependency assays. Our findings were validated in human PJS-derived tissues using immunohistochemistry and linked to colorectal cancer profiles using the TCGA cancer database. Results Our results reveal that heterozygous Lkb1 loss is sufficient to push intestinal cells into a premalignant transcriptional program associated with serrated colorectal cancer, which is further amplified by loss-of-heterozygosity. This altered epithelial growth state associates with persistent features of regeneration and enhanced EGFR ligand and receptor expression, conferring niche-independent growth properties to Lkb1-deficient organoids. Moreover, our newly generated LKB1-mutant signature is enriched in sporadic serrated colorectal cancer, and synergistic cooperation of Lkb1-deficiency with mutant Kras was experimentally confirmed by assessing organoid growth properties and transcriptomes. Conclusions Heterozygous loss of LKB1 pushes intestinal cells into a chronic regenerative state which is amplified upon loss-of-heterozygosity. Lkb1-deficiency thereby generates fertile ground for serrated colorectal cancer formation in the intestine, potentially explaining the increased cancer risk observed in PJS.</description><dates><publication>2026/04/20</publication></dates><accession>GSE302659</accession><cross_references><GSM>GSM9108390</GSM><GSM>GSM9108391</GSM><GSM>GSM9108392</GSM><GSM>GSM9108393</GSM><GSM>GSM9108394</GSM><GSM>GSM9108395</GSM><GSM>GSM9108396</GSM><GSM>GSM9108375</GSM><GSM>GSM9108397</GSM><GSM>GSM9108376</GSM><GSM>GSM9108398</GSM><GSM>GSM9108399</GSM><GSM>GSM9108377</GSM><GSM>GSM9108410</GSM><GSM>GSM9108378</GSM><GSM>GSM9108379</GSM><GSM>GSM9108380</GSM><GSM>GSM9108381</GSM><GSM>GSM9108382</GSM><GSM>GSM9108383</GSM><GSM>GSM9108384</GSM><GSM>GSM9108385</GSM><GSM>GSM9108405</GSM><GSM>GSM9108406</GSM><GSM>GSM9108407</GSM><GSM>GSM9108408</GSM><GSM>GSM9108409</GSM><GSM>GSM9108386</GSM><GSM>GSM9108387</GSM><GSM>GSM9108388</GSM><GSM>GSM9108400</GSM><GSM>GSM9108389</GSM><GSM>GSM9108401</GSM><GSM>GSM9108402</GSM><GSM>GSM9108403</GSM><GSM>GSM9108404</GSM><GPL>19057</GPL><GPL>30172</GPL><GSE>302659</GSE><taxon>Mus musculus</taxon><PMID>[41128695]</PMID></cross_references></HashMap>